LATIN AMERICA BONE DENSITOMETER MARKET 2022-2028

Latin America Bone Densitometer Market 2022-2028

MARKET OUTLOOK

The bone densitometer market in Latin America is predicted to exhibit growth with a CAGR of 4.18% in the forecast duration from 2022 to 2028, according to a report by Triton Market Research. Mexico, Brazil, and Rest of Latin America together shape the market in this region. Argentina is an eminent country in Rest of Latin America.

The Argentinian Society of Osteology and Mineral Metabolism (AAOMM) and the Argentinian Society of Osteoporosis (SAO) are the two national-level scientific societies working on basic and clinical research in mineralized tissue. In 2009, the country’s total population was 40 million people, with 10 million people aged over 50 years. By 2050, this population is estimated to grow by 13% and reach 53 million, and the number of elderly is estimated to reach 19.5 million people.

Local bone mineral density studies show that 2 out of 4 postmenopausal women are affected by osteopenia. Of these 4, 1 is affected by osteoporosis, while 1 has normal bone mineral density. Close to 3.3 million women are likely to be affected by osteopenia by 2025, and this number is expected to reach 5.24 million by 2050. The rate of fragility fractures is higher in osteoporosis patients. However, the absolute number of fractures is higher in patients with osteopenia.

In Argentina, the mean annual rate of hip fractures in patients aged above 50 years is 488/100,000, with an F/M ratio of 2.6:1. Thus, more than 34,000 hip fracture cases are reported every year in the elderly population, with an average of 90 fractures every day. According to a study, the overall prevalence of vertebral fractures among Argentinean women aged 50 years or greater is 16.2%.

Moreover, the hospitalization costs for vertebral and hip fractures in the country exceed $190 million each year. Thus, the cost for the public health system for osteoporosis is staggering. However, it is currently not prioritized by the federal and provincial governments in the country. To conclude, the authorities need to make dedicated and consistent efforts for osteoporosis prevention and management. This will likely expand the scope of the bone densitometer in the country.

COMPETITIVE OUTLOOK

Major players engaged in the bone densitometer market include Oscar Medical Oy, BeamMed Ltd, GE Healthcare, Trivitron Healthcare, Eurotec Systems Srl, Scanflex Healthcare AB, Medilink, and L Acn L Accessorio Nucleare Srl.